[1]
Abas, G.M., Sjatha, F. and Rosana, Y. 2023. The Risk of Latent Tuberculosis Reactivation in COVID-19 Therapy. Jurnal Biomedika dan Kesehatan. 6, 3 (Dec. 2023), 363–372. DOI:https://doi.org/10.18051/JBiomedKes.2023.v6.363-372.